会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 17BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS
    • 17BETA-HYDROXYSTERIDID DEHYDROGENASE INHIBITOREN
    • EP1631579A2
    • 2006-03-08
    • EP04722316.9
    • 2004-03-22
    • Sterix Limited
    • VICKER, Nigel, Sterix LimitedLAWRENCE, Harshani Rithma R., Sterix LimitedALLAN, Gillian Margaret, Sterix LimitedBUBERT, Christian, Sterix LimitedFISCHER, Delphine Sophie Marion, Sterix LimitedPUROHIT, Alan, Sterix LimitedREED, Michael John, Sterix LimitedPOTTER, Barry Victor Lloyd, Sterix Limited
    • C07J1/00A61K31/56A61K31/566C07J41/00
    • C07J71/00C07J41/00
    • There is provided a compound of Formula (I) wherein (I) R1 is a selected from (i) an alkyloxyalkyl group (ii) a nitrile group, and wherein R2 is capable of forming a hydrogen bond (iii) alkylaryl group, wherein the aryl group is substituted by other than a C1-10 group (iv) alkenylaryl group wherein the aryl group is substituted (v) alkyiheteroaryl group, wherein when heteroaryl group comprises only C and N in the ring, the aryl group is substituted by other than a methyl group (vi) alkenylheteroaryl group, (vii) =N-O-alkyl or =N-O-H group (viii) branched alkenyl (ix) alkyl-alcohol group (x) amide or alkylamide wherein (a) the alkyl of the alkylamide is - CH2- or -CH2CH2-, (b) the amide is di-substituted and/or (c) the amide is substituted with at least one of a I kyl heterocycle group, al ke nyl heterocycle group, alkylheteroaryl group, alkenylheteroaryl group, heteroaryl group, alkylamine group, alkyloxyalkyl group, alkylaryl group, straight or branched alkyl group, (xi) -CHO so that R, together with R3 provide the enol tautomer (a); OR R1 together with R3 form (xii) a pyrazole wherein (a) R4 is =N-0-alkyl or =N-0-H group, (b) the pyrazole is substituted with one of alkyl-OH group, alkyl ester group, alkyloxyalkyl. group, branched alkyl group, and an amide and/or (c) the 2 position is substituted with a group selected from -OH and -0-hydrocarbyl (xiii) a heteroaryl ring to provide a compound of the formula (b); (II) R2 is selected from groups capable of forming a hydrogen bond, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group and a sulphonamide group; and (III) R3 is selected from -OH, =O, or a -C(=O)- mimetic.
    • 提供式I的化合物,其中(I)R 1选自(i)烷氧基烷基(ii)腈基,其中R 2能够形成氢键(iii)烷基芳基,其中 芳基被其它芳基取代的(C 1〜C 10)烯基芳基(ⅴ)烷基杂芳基取代,其中当杂芳基仅在环中仅包含C和N时,芳基被除 (vi)烯基杂芳基,(vii)= NO-烷基或= NOH基(viii)支链烯基(ix)烷基醇基(x)酰胺或烷基酰胺,其中(a)烷基酰胺的烷基是-CH 2 - 或-CH 2 CH 2 - ,(b)酰胺是二取代的和/或(c)酰胺被烷基杂环基,烯基杂环基,烷基杂芳基,烯基杂芳基,杂芳基,烷基胺中的至少一个所取代 基团,烷氧基烷基,烷基芳基,直链或支链烷基,(xi)-CHO,使得 R 1与R 3一起提供烯醇互变异构体OR R 1和R 3形式(xii)吡唑,其中(a)R 4是= NO-烷基或= NOH基,(b)吡唑被烷基 -OH基,烷基酯基,烷氧基烷基,支链烷基和酰胺和/或(c)2位被选自-OH和-O-烃基(xiii)杂芳基环的基团取代,以提供 式(II)化合物R 2选自能够形成氢键,氨基磺酸酯基,膦酸酯基,硫代膦酸酯基,磺酸酯基和磺酰胺基的基团; 和(III)R 3选自-OH,= O或-C(= O) - 模拟物